1. Introduction {#sec1}
===============

Secondary metabolites of fungi, plants, and bacteria have long been used as medicines and supplements ([@bib16]). Compounds such as naringenin, raspberry ketone, resveratrol, and curcumin are widely used nutraceuticals and are biosynthesized through similar pathways ([@bib15]; [@bib29]; [@bib48]; [@bib50]). Commercially, these chemicals are either extracted directly from plants or produced synthetically, as in the case of raspberry ketone ([@bib50]). Renewable microbial production of these compounds will decrease reliance on agriculture and fossil fuel-derived chemical synthesis. The biosynthesis of these compounds (naringenin, raspberry ketone, resveratrol, and curcumin) relies on a class of enzymes called type III polyketide synthases (T3PKSs). T3PKSs carry out iterative Claisen condensation reactions typically with coenzyme A (CoA)-based starter and extender units ([@bib61]). In the case of the 1,3,6,8-tetrahydroxynapthalene synthase of *Streptomyces coelicolor* (RppA) the starter and extender units are simply malonyl-CoA, while in many plant T3PKSs the starter unit is a phenylpropanoyl-CoA thioester, usually derived from ferulate, coumarate, or cinnamate ([@bib19]; [@bib55]).

Coumarate and ferulate are components of lignin found in lignocellulosic hydrolysate (LH), which has been proposed for use as a renewable feedstock for biocatalysis ([@bib23]; [@bib31]). Characteristics such as high solvent tolerance and diverse carbon metabolisms are essential for microbes to be used in LH valorization. However, these robust traits are lacking in commonly used model organisms, such as *Escherichia coli*, hindering progress toward making LH a viable feedstock ([@bib34]). Rather than developing these characteristics in a microorganism *de novo*, a clear alternative is to source a microbe with the desirable traits already available to it. The saprophytic bacterium *Pseudomonas putida* has long been studied for its ability to catabolize aromatic compounds and withstand solvents, making it an attractive host for LH upcycling ([@bib13]; [@bib32]; [@bib37]).

In this work we sought to leverage the native catabolism of *P. putida* KT2440 for use in the biosynthesis of a plant T3PKS product from coumarate. RppA of *S. coelicolor* was first expressed to determine production conditions conducive to T3PKS product accumulation. Using a randomly barcoded transposon mutant (RB-TnSeq) library of *P. putida*, we assayed for genes involved in the catabolism of coumarate and seven other related aromatic compounds. We then found that accumulation of coumaroyl-CoA by the activity of Fcs was toxic to *P. putida*. The native feruloyl/coumaroyl-CoA synthetase (Fcs) of *P. putida* was then used to produce the coumaroyl-CoA starter unit to the curcuminoid synthase (CUS) of *Oryza sativa*. Finally, relying on the native expression levels of *fcs* from the chromosome and plasmid-based expression of *CUS* ([Fig. 1](#fig1){ref-type="fig"}), production of bisdemethoxycurcumin (BDC) from coumarate was achieved.Fig. 1Diagram of the engineered *P. putida* strain used to produce bisdemethoxycurcumin. Fcs is the feruloyl/coumaroyl-CoA synthetase native to *P. putida* KT2440. Ech is the native enoyl-CoA hydratase-lyase which carries out the second step in coumarate catabolism and was knocked out in our production host. CUS is the curcuminoid synthase from *O. sativa.* BDC is the final curcuminoid product, bisdemethoxycurcumin.Fig. 1

2. Results {#sec2}
==========

2.1. RppA as a screen for optimal T3PKS production conditions {#sec2.1}
-------------------------------------------------------------

The tetrahydroxynaphthalene synthase of *Streptoyces coelicolor* was recently applied as a biosensor for malonyl-CoA concentrations in several hosts including *P. putida* ([@bib60]). We sought to express this protein from the broad host range pBADT vector to assay culture conditions for increased product accumulation in *P. putida*. RppA was initially codon optimized for expression in *P. putida* and cloned into the construct pBADT-*rppA*-OW. We then constructed two more plasmids, one with the complete *rppA* cloned from the *S. coelicolor* genome (pBADT-*rppA*-NW) and another with a 3' truncation of 75 base pairs (pBADT-*rppA*-NT) as this had been described previously to increase enzymatic activity ([@bib19]).

Since the product of RppA, 1,3,6,8-tetrahydroxynaphthalene, spontaneously oxidizes to the red pigment flaviolin, we used a colorimetric assay to determine how glucose concentrations affect the production of T3PKS products ([Fig. 2](#fig2){ref-type="fig"}A). Concentrations of glucose ranging from 0 - 400 ​mM supplemented into LB medium were tested, and the production of flaviolin was measured by absorbance at 340 ​nm, as previously reported ([@bib60]). Unexpectedly, the *rppA* expression vectors using the native *S. coelicolor* codons produced more flaviolin than the *P. putida* codon optimized variant ([Fig. 2](#fig2){ref-type="fig"}B). In all three constructs tested, there was an increase in the accumulation of flaviolin in cultures containing greater than 25 ​mM glucose and accumulation of flaviolin appeared to plateau at \~100 ​mM glucose ([Figs. 2](#fig2){ref-type="fig"}B and [S4](#appsec1){ref-type="sec"}). To validate the observed red compound was flaviolin, we extracted, purified, and obtained an ^1^H-NMR spectrum for the red product using established methods ([Figs. S5A and S5B](#appsec1){ref-type="sec"}) ([@bib12]; [@bib52]). The final yield from 100 ​mL of culture was \~6.5 ​mg.Fig. 2Flaviolin production as a reference for T3PKS activity. (A) Diagram of the pathway to the red pigment, flaviolin, from RppA and subsequent spontaneous oxidation. (B) Absorbance measurements at 340 ​nm of supernatants from cells expressing RppA variants in LB containing different concentrations of glucose. Error bars indicate the standard deviation of three trials. RppA-NW contains natural *S. coelicolor* codons, RppA-NT is the same as RppA-NW but with a C-terminal truncation of 25 ​amino acids, and RppA-OW is translated from a transcript that was codon optimized for *P. putida.* (C) RppA expression profile as determined by mass spectrometry from lysates of cultures producing the RppA variants. The No RppA sample was extracted from *P. putida* KT2440 carrying pBADT-RFP. Error bars indicate the standard deviation of three replicates. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

Following this result, we sought to identify if increased protein abundance was the cause for increased flaviolin production. When RppA was quantified using LC-MS, we observed an increase in its relative abundance for all variants when 100 ​mM glucose was supplemented to the medium. The abundance of RppA also was highest in the strains expressing the native genomic sequence of *rppA* ([Fig. 2](#fig2){ref-type="fig"}C).

2.2. Functional genomics to validate aromatic catabolisms of *P. putida* {#sec2.2}
------------------------------------------------------------------------

While aromatic catabolism has been extensively studied in *P. putida*, essential genes implicated in these pathways have been described as recently as 2019 ([@bib43]). The genes involved in the first steps of coumarate catabolism reside in an operon with a putative acyl-CoA dehydrogenase (*PP_3354*) and a putative beta-ketothiolase (*PP_3355*), which have been proposed to be involved in an alternative catabolic pathway ([@bib38]). As functional redundancy in coumarate catabolism could result in loss of the type III polyketide precursor, coumaroyl-CoA, we sought to identify any pathways that could potentially impact product titers. To assay for genes involved in coumarate and related aromatic metabolisms, we grew a randomly barcoded transposon mutant (RB-TnSeq) library of *P. putida* KT2440 in minimal medium with a variety of different aromatic compounds often found in LH (p-coumarate, ferulate, benzoate, p-hydroxybenzoate, protocatechuate, vanillin, vanillate, phenylacetate) and glucose as sole carbon sources. The fitness of each gene was calculated by comparing the abundance of barcodes before versus after growth selection, using barcode sequencing (BarSeq) ([@bib46]; [@bib57]). Negative values indicate that the gene was important for growth in that condition.

The results of the RB-TnSeq assay validated that the primary route for ferulate and coumarate catabolism is through the feruloyl/coumaroyl-CoA synthetase (Fcs) and the enoyl-CoA hydratase lyase (Ech) ([Fig. 3](#fig3){ref-type="fig"} and [Fig. S1](#appsec1){ref-type="sec"}). The genes in the proposed secondary pathway of coumarate and ferulate catabolism, *PP_3354* and *PP_3355*, had no significant fitness phenotype, indicating that these genes are likely not necessary for coumarate or ferulate catabolism ([@bib42]).Fig. 3Overview of aromatic catabolism in *P. putida* KT2440. The colored and labelled compounds depicted were fed as sole carbon sources to the barcoded transposon library. Fitness values for each gene are the average of 2 replicate RB-TnSeq assays, and are colored corresponding to the carbon source (gray: benzoate, red: coumarate, blue: 4-hydroxybenzoate, light green: ferulate, dark green: vanillate, purple: vanillin, yellow: protocatechuate, pink: phenylacetate). For reactions where multiple genes are necessary, i.e. enzyme complexes, the fitness values for each gene involved in the reaction were averaged. \*The t-score for *pcaC* was insignificant (\|t~score~\| ​\< ​4.0) and was excluded from our analysis. \*\*Fitness values for these genes were mild (fitness ​\> ​−2.0) and excluded. \*\*\*Fitness value corresponds to *paaJ*. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)Fig. 3

Of all the known reactions depicted in the map of aromatic catabolism ([Fig. 3](#fig3){ref-type="fig"}), we observed significant negative fitness values for all but three of their corresponding genes: *catA-1*, *catA-2*, and *pcaC*. Even though the fitness score was higher than our cutoff at −1.4, *catA-*1 had a significant \|t-score\| of 6.2 when grown on benzoate. This reflects previous work demonstrating CatA-I is the preferred catechol 1,2-dioxygenase, while CatA-II acts as a "safety valve" to handle high intracellular concentrations of catechol. It was also demonstrated that both catA-I and catA-II need to be deleted to abolish growth on benzoate, and this likely explains why the fitness value for catA-I was above our cut-off ([@bib22]). In the case of *pcaC*, we noticed that there was a strong phenotype (fitness ​\< ​−2.0), but the significance fell below our cutoff in all conditions tested (\|t~score~\| ​\< ​4.0). This is likely due to the low frequency of transposon insertions into this gene in the library (n ​= ​4).

While our results heavily support the current models of aromatic metabolism in *P. putida*, our data also indicated that some gene annotations should be revised. *PP_3272* is currently annotated as encoding an acetate permease ([@bib24]; [@bib26]; [@bib25]). We observed that *PP\_*3272 had a significant phenotype when grown on phenylacetate ([Fig. 3](#fig3){ref-type="fig"}). Given these data and previously described homology to other systems ([@bib21]), *PP_3272* should be reannotated as the phenylacetate transporter (phaJ). The *PP_1376* gene is annotated as encoding a 4-hydroxybenzoate transporter ([@bib24]; [@bib26]; [@bib25]); however, we only observed a fitness detriment for this gene with protocatechuate as the sole carbon source ([Fig. 3](#fig3){ref-type="fig"}). Because of this, *PP_1376* should be reannotated as a protocatechuate transporter.

2.3. Accumulation of coumaroyl-CoA is toxic to *P. putida* {#sec2.3}
----------------------------------------------------------

The first step in the biosynthetic pathway for bisdemethoxycurcumin is the activation of coumarate with coenzyme A (CoASH) ([Fig. 1](#fig1){ref-type="fig"}). Because *Pseudomonas putida* KT2440 natively produces coumaroyl-CoA during coumarate catabolism, we knocked out the subsequent gene in the native catabolic pathway, *ech*, to prevent *P. putida* from consuming this necessary precursor ([Fig. 1](#fig1){ref-type="fig"}) ([@bib21]). Initial production experiments in Δ*ech* strains overexpressing *fcs* and *CUS* from a synthetic operon resulted in an extended lag phase (data not shown). To determine the cause, we overexpressed *fcs* alone under control of the arabinose-inducible *araBAD* promoter (P~BAD~) in the presence and absence of coumarate. Increasing the inducer concentration resulted in increased lag times only when coumarate was present in the medium ([Figs. 4](#fig4){ref-type="fig"}A and [S6](#appsec1){ref-type="sec"}). This suggested that the coumaroyl-CoA intermediate is toxic to *P. putida*.

To determine if coumaroyl-CoA concentrations are elevated in cultures expressing *fcs*, cultures carrying pBADT-*fcs* were induced with L-arabinose. After a 7 h growth period, 5 ​mM coumarate was supplemented to the medium. Following supplementation, growth was stunted and remained relatively constant over the course of 11 ​h. The concentration of coumaroyl-CoA was highest in samples 1 ​h after coumarate was supplemented into the medium; this was observed regardless of the *ech* genotype ([Fig. 4](#fig4){ref-type="fig"}B). We therefore sought to minimize the burden of this intermediate by relying on the native chromosomal expression of fcs in future experiments.Fig. 4Production of coumaroyl-CoA inhibits growth of *P. putida.* (A) 24 ​h growth curves of KT2440 Δ*ech* carrying pBADT-*fcs* in LB induced with varying concentrations of arabinose and no added coumarate (left), or 5 ​mM coumarate (right). Error bars are ​± ​the standard deviation of three replicates. (B) Growth curve (left) and normalized abundance of coumaroyl-CoA (right) in KT2440 (WT) and KT2440 Δ*ech* (Δ*ech*). Cultures expressing *fcs* were supplemented with 0 or 5 ​mM coumarate at hour 7 (marked with dashed line). Coumaroyl-CoA concentrations were normalized by OD~600~. Error bars are ​± ​the standard deviation of three replicates.Fig. 4

2.4. Production of bisdemethoxycurcumin {#sec2.4}
---------------------------------------

In order to produce bisdemethoxycurcumin in *P. putida*, we constructed the biochemical pathway outlined in [Fig. 1](#fig1){ref-type="fig"}. Exogenously added coumarate is activated by the native feruloyl/coumaroyl-CoA synthetase of *P. putida* (Fcs), then two resultant coumaroyl-CoA molecules are condensed with malonyl-CoA by the curcuminoid synthase of *O. sativa* (CUS) to yield bisdemethoxycurcumin ([@bib28]). The CoA synthetase, *fcs*, was expressed from its native chromosomal locus, while *CUS* was expressed from the pBADT plasmid and induced with L-arabinose ([@bib3]).

Our initial production strategy was to induce *CUS* until the cultures reached stationary phase. Then the cultures were pelleted and resuspended in fresh LB medium supplemented with 5 ​mM coumarate. These samples were then incubated for another 72 ​h. A similar approach had been used successfully in *E. coli* ([@bib27]); however, our titers were less than 0.5 ​mg/L ([Fig. S2](#appsec1){ref-type="sec"}). Given that bisdemethoxycurcumin is insoluble in water ([@bib20]), a 10% v/v oleyl alcohol overlay was used to extract the product as the fermentation progressed. Production levels were low (approximately 0.1 ​mg/L) in *P. putida* Δ*ech* when the medium was supplemented with 10 ​mM coumarate, likely due to the toxicity of coumaroyl-CoA ([Fig. 5](#fig5){ref-type="fig"}). Supplementation with 5 ​mM coumarate resulted in a \~5-fold increase in bisdemethoxycurcumin titers in the *P. putida* Δ*ech* strain relative to wild-type ([Fig. 5](#fig5){ref-type="fig"}).Fig. 5Bisdemethoxycurcumin titers in *P. putida* KT2440 Δ*ech* and in wildtype KT2440 harboring pBADT-CUS. *CUS* was induced with 2% w/v L-arabinose. Error bars are ​± ​the standard deviation of three biological replicates.Fig. 5

3. Discussion {#sec3}
=============

*Pseudomonas putida* is among the most well studied saprophytic bacteria. Its diverse metabolisms enable it to catabolize a wide variety of complex carbon sources, including lignocellulosic hydrolysate ([@bib56]). The robust catabolic pathways of *P. putida*, while useful for producing valuable molecules from diverse carbon sources, can also serve as an obstacle to achieving high product titers as it can often metabolize the desired products ([@bib54]). Given recent advances in gene editing techniques ([@bib2], [@bib1]; [@bib7]; [@bib33]; [@bib59]) and our ability to rapidly assay for gene function with transposon site sequencing ([@bib44]; [@bib46]; [@bib57]), engineering non-model hosts like *P. putida* for industrial applications has become less challenging.

Using RB-TnSeq mutant fitness assays we were able to rapidly confirm entire pathways of aromatic catabolism ([Figs. 3](#fig3){ref-type="fig"} and [S1](#appsec1){ref-type="sec"}). The genes downstream of *fcs*, *PP_3354* and *PP_3355* previously described as a possible alternative route for coumarate/ferulate catabolism ([@bib21]; [@bib38]; [@bib45]), showed no significant fitness detriment on any of the carbon sources tested. These genes may be structural remnants of a β-oxidation pathway that eventually evolved into the coumarate/ferulate pathway requiring *fcs*, *ech*, and *vdh* ([@bib21]; [@bib38]; [@bib45]). We then proposed revised annotations of two genes required for transport of the aromatic compounds, phenylacetate (*PP_3272*) and protocatechuate (*PP_1376*), an important plant hormone and lignin metabolite respectively ([@bib58]). There is a large amount of information in these data encompassing regulatory and structural genetic elements that could be useful to engineers and biologists.

Heterologous expression of bacterial T3PKSs, including the tetrahydroxynapthalene synthase of *S. coelicolor* (RppA), has previously been demonstrated in *P. putida* KT2440 ([@bib12]; [@bib60]). Using variants of *rppA*, we were able to rapidly screen type III polyketide production conditions. Expressing the codon optimized variant we created in this study, *rppA*-OW, resulted in less flaviolin production and less protein production than the native codon variants *rppA*-NW and *rppA*-NT. It is possible that there are some factors affecting heterologous protein expression that are not sufficiently accounted for in current codon optimization algorithms ([@bib4]). However, we demonstrated in all our constructs that increasing the glucose concentration had a considerable effect on the production of flaviolin ([Figs. 2](#fig2){ref-type="fig"} and [S4](#appsec1){ref-type="sec"}).

Higher flaviolin accumulation with increased glucose concentrations could be due to increased flux to malonyl-CoA, a known limiting reactant to the biosynthesis of plant T3PKS products ([@bib29]; [@bib62]), or due to increased functional protein expression. As the relative abundance of RppA increased when the culture was grown in the presence of 100 ​mM glucose, we hypothesize this likely contributed to the increased flaviolin titer observed in this condition ([Fig. 2](#fig2){ref-type="fig"}B and C). The exact cause for the increase in protein abundance requires more detailed investigation. These T3PKS "sensors" have broad utility in both rapidly assaying culture conditions, as described here, and as high-throughput screens of genetic libraries for increased malonyl-CoA accumulation ([@bib60]). Future work could employ these sensors to screen for increased intracellular malonyl-CoA concentrations from a complex growth medium like LH.

To provide the coumaroyl-CoA substrate for the bisdemethoxycurucumin T3PKS, CUS, we sought to use the native CoA synthetase (Fcs) of *P. putida*. Plasmid-based induction of *fcs* expression in the presence of coumarate, however, resulted in an increase in lag times due to the build-up of the toxic coumaroyl-CoA intermediate ([Figs. 4](#fig4){ref-type="fig"}A, 4B, and [S6](#appsec1){ref-type="sec"}). Neither the accumulation of coumaroyl-CoA nor the resultant growth inhibition seemed to be significantly affected by the genetic presence of *ech* ([Fig. 4](#fig4){ref-type="fig"}B). The reduction in intracellular coumaroyl-CoA concentrations following the addition of coumarate was also not dependent on the presence of *ech* ([Fig. 4](#fig4){ref-type="fig"}B). This reduction in thioester concentrations may be the result of nonspecific thioesterase activity, or spontaneous hydrolysis of coumaroyl-CoA.

The toxicity of hydroxycinnamate thioesters has been reported in *Acinetobacter baylyi* following disruptions in the gene encoding its enoyl-CoA hydratase lyase, and it was observed in *E. coli* expressing the *A. baylyi fcs* homolog in the presence of coumarate ([@bib39]). This toxicity could have been limiting other systems using bacterial coumaroyl-CoA synthetases, but the defective growth phenotype may not have been observed due to differences in experimental design ([@bib41]; [@bib47]). The exact cause for coumaroyl-CoA toxicity remains unclear and will be the subject of future investigations.

To engineer *P. putida* for bisdemethoxycurcumin production, we deleted the native enoyl-CoA hydratase lyase (*ech*) responsible for the conversion of coumaroyl-CoA to acetyl-CoA and p-hydroxybenzaldehyde. In order to relieve some of the observed coumaroyl-CoA toxicity, we relied on the native genomic copy of *fcs* instead of a plasmid-based system. We demonstrated that native expression of *fcs* generates sufficient coumaroyl-CoA for curcuminoid synthase (CUS). Extraction of the product during growth using an oleyl alcohol overlay also significantly enhanced titers ([Figs. S2 and 5](#appsec1){ref-type="sec"}). In the final *P. putida* production strain, we achieved production of bisdemethoxycurcumin at titers of 2.15 ​mg/L ([Fig. 5](#fig5){ref-type="fig"}).

This work is a significant first step towards the production of plant T3PKS-derived compounds in *P. putida*, but several issues remain to be addressed. In particular, our final bisdemthoxycurcumin titer of 2.15 ​mg/L is far lower than the 91.3 ​mg/L titer first described in *E. coli* ([@bib29]). Several methods have been proposed to enhance the production of curcuminoids and similar T3PKS derived compounds in microbial hosts. In one such approach, the metabolic burden of product, protein, and plasmid DNA synthesis was spread across several microbial strains in a synthetic co-culture ([@bib9]). Since phenylpropanoid overproducing strains of *P. putida* have been described ([@bib36], [@bib35]), a co-culture method could be explored for the biosynthesis of plant T3PKS products in this host. It is also quite clear that more extensive pathway balancing will be required to mitigate the intermediate toxicity we have observed. As we continue to understand more about the metabolism of *P. putida* and learn to engineer it more effectively, this host will become an increasingly attractive chassis for renewable chemical biosynthesis.

4. Methods {#sec4}
==========

4.1. Media, chemicals, and culture conditions {#sec4.1}
---------------------------------------------

General *E. coli* cultures were grown in Luria-Bertani (LB) Miller medium (BD Biosciences, USA) at 37 ​°C, while *P. putida* was grown at 30 ​°C. MOPS minimal medium was used where indicated and comprised of the following: 32.5 ​μM CaCl~2~, 0.29 ​mM K~2~SO~4~, 1.32 ​mM K~2~HPO~4~, 8 ​μM FeCl~2~, 40 ​mM MOPS, 4 ​mM tricine, 0.01 ​mM FeSO~4~, 9.52 ​mM NH~4~Cl, 0.52 ​mM MgCl~2~, 50 ​mM NaCl, 0.03 ​μM (NH~4~)~6~Mo~7~O~24~, 4 ​μM H~3~BO~3~, 0.3 ​μM CoCl~2~, 0.1 ​μM CuSO~4~, 0.8 ​μM MnCl~2~, and 0.1 ​μM ZnSO~4~ ([@bib30]). Cultures were supplemented with kanamycin (50 ​mg/L, Sigma Aldrich, USA) when indicated. Technical grade oleyl alcohol was acquired from Alfa Aesar (Alfa Aesar, Thermo Fisher Scientific). Coenzyme A (lithium salt) was purchased from CoALA Biosciences (CoALA Biosciences, USA). All other compounds were purchased through Sigma Aldrich (Sigma Aldrich, USA). Construction of *P. putida* deletion mutants was performed as described previously ([@bib53]).

4.2. Strains and plasmids {#sec4.2}
-------------------------

Bacterial strains and plasmids used in this work are listed in [Table 1](#tbl1){ref-type="table"}. All strains and plasmids created in this work are available through the public instance of the JBEI registry <https://public-registry.jbei.org>. All plasmids were designed using Device Editor and Vector Editor software, while all primers used for the construction of plasmids were designed using j5 software ([@bib5]; [@bib14]; [@bib17]). Plasmids were assembled via Gibson Assembly using standard protocols ([@bib10]), or Golden Gate Assembly using standard protocols ([@bib8]). Plasmids were routinely isolated using the Qiaprep Spin Miniprep kit (Qiagen, USA), and all primers were purchased from Integrated DNA Technologies (IDT, Coralville, IA).Table 1Strains and plasmids used in this study.Table 1StrainJBEI Part IDReference*E. coli* DH10B[@bib11]*E. coli* BL21 (DE3)Novagen*P. putida* KT2440ATCC 47054*P. putida* KT2440 Δ*ech*PlasmidspET28NovagenpBADT[@bib3]pBADT-*CUS*JBx_134311This workpBADT-*rppA*-NTJBx_134312This workpBADT-*rppA*-NWJBx_134313This workpBADT-*rppA*-OWJBx_134314This workpBADT-*fcs*JBx_134315This workpBADT-*fcs-CUS*JBx_134316This workpMQ30[@bib49]pMQ30-*PP_3358*[@bib40]

4.3. Plate based growth assays {#sec4.3}
------------------------------

Growth studies of bacterial strains were conducted using microplate reader kinetic assays. Overnight cultures were inoculated into 10 ​mL of LB medium from single colonies, and grown at 30 ​°C. These cultures were then diluted 1:100 into 500 ​μL of LB medium with appropriate concentrations of arabinose and p-coumarate in 48-well plates (Falcon, 353072). Plates were sealed with a gas-permeable microplate adhesive film (VWR, USA), and optical density and fluorescence were monitored for 48 ​h in a Biotek Synergy 4 plate reader (BioTek, USA) at 30 ​°C with fast continuous shaking. Optical density was measured at 600 ​nm. The amount of time necessary for the culture to reach an OD~600~ of 0.16 was defined as the lag time.

4.4. HPLC detection of bisdemethoxycurcumin {#sec4.4}
-------------------------------------------

HPLC analysis was performed on an Agilent Technologies 1200 series liquid chromatography instrument coupled to a Diode Array Detector (Agilent Technologies, USA). Compounds were separated at a constant flow rate of 0.4 ​mL/min over a Kinetex C18 column (2.6 ​μm diameter, 100 ​Å particle size, dimensions 100 ​× ​3.00 ​mm, Phenomenex, USA) held at 50 ​°C. The mobile phase consisted of H~2~O + 0.1% trifluoroacetic acid (A) and acetonitrile ​+ ​0.1% trifluoroacetic acid (B). Separation was performed using the following gradient method: 0--3 ​min 95% A, 3--15 ​min 95-5% A, 15--17 ​min 5% A, 17--17.5 ​min 5--95% A, 17.5--20 ​min 95% A. The presence of bisdemethoxycurcumin was monitored and quantified at 440 ​nm.

4.5. RB-TnSeq experiments and analysis {#sec4.5}
--------------------------------------

BarSeq-based experiments utilized the *P. putida* RB-TnSeq library, JBEI-1, which has been described previously ([@bib53]). An aliquot of JBEI-1 was thawed on ice, diluted into 25 ​mL of LB medium supplemented with kanamycin and grown to an OD~600~ of 0.5 ​at 30 ​°C. Three 1 ​mL aliquots of the library were pelleted and stored at −80 ​°C to later serve as the t~0~ of gene abundance. Libraries were then washed in MOPS minimal medium and diluted 1:50 in MOPS minimal medium with 10 ​mM p-coumarate, ferulate, benzoate, p-hydroxybenzoate, protocatechuate, vanillin, vanillate, phenylacetate, or D-glucose. Cells were grown in 600 ​μL of medium in 96-well deep well plates (VWR). Plates were sealed with a gas-permeable microplate adhesive film (VWR, USA), and then grown at 30 ​°C in an INFORS HT Multitron (Infors USA Inc.), with shaking at 700 ​rpm. Two 600-μL samples were combined, pelleted, and stored at −80 ​°C until analysis by BarSeq, which was performed as previously described ([@bib46]; [@bib57]). All fitness data are publicly available at <http://fit.genomics.lbl.gov>.

4.6. Curcuminoid production {#sec4.6}
---------------------------

For production of bisdemthoxycurcumin without an overlay, an overnight culture of *P. putida* KT2440 Δ*ech* ​+ ​pBADT-CUS was diluted 1:100 into 5 ​mL of LB supplemented with 50 ​mg/L kanamycin, 1% w/v L-arabinose, and 100 ​mM glucose. The culture was grown to stationary phase over 12 ​h then pelleted in a centrifuge at 5000×*g* for 5 ​min. The cell pellets were resuspended in 2 ​mL of fresh LB with 50 ​mg/L kanamycin, 0.5% L-arabinose, 100 ​mM glucose, and 5 ​mM coumarate. The culture was allowed to proceed for 72 ​h.

For experiments employing an overlay, overnights of *P. putida* harboring pBADT-CUS were diluted 1:100 into 25 ​mL of fresh LB supplemented with 50 ​mg/L kanamycin, and 100 ​mM glucose. Arabinose and coumarate were added at the beginning of the fermentation at concentrations indicated. A 2.5 ​mL overlay of oleyl alcohol was added to extract the bisdemethoxycurcumin during growth. The fermentation was allowed to proceed for 72 ​h.

4.7. Curcuminoid extraction {#sec4.7}
---------------------------

For cultures lacking an overlay, 0.5 ​mL of culture was acidified to pH 3 with 3 ​N HCl. Bisdemethoxycurcumin was then extracted with an equal volume of ethyl acetate. 250 ​μL of the ethyl acetate layer was removed and the solvent was allowed to evaporate overnight. The dried samples were then resuspended in 50 ​μL of acetonitrile for analysis with HPLC-DAD.

For cultures with an overlay, the cultures were acidified to pH 3 with 3 ​N HCl. Acidified cultures were then pelleted in a centrifuge and the oleyl alcohol overlays were removed. To quantify bisdemethoxycurcumin, 100 ​μL of the extracted overlays were added to a black, clear bottom 96-well plate and absorbance was measured at 425 ​nm in a Biotek Synergy 4 plate reader (BioTek, USA). A standard curve was made with bisdemethoxycurcumin standards dissolved in oleyl alcohol ([Fig. S3](#appsec1){ref-type="sec"}).

4.8. Flaviolin production and targeted proteomic analysis {#sec4.8}
---------------------------------------------------------

Colonies of *P. putida* KT2440 strains carrying pBADT-*rppA*-NW, pBADT-*rppA*-NT, and pBADT-*rppA*-OW were used to inoculate LB or MOPS minimal medium with 50 ​mg/L kanamycin and cultured overnight. The overnight culture was then diluted 1/100 into fresh medium with 0.2% w/v L-arabinose, 50 ​mg/L kanamycin, and 400, 200, 100, 50, 25, 12.5, 6.25 or 0 ​mM glucose. Cultures were conducted in 24-well deep-well plates and allowed to proceed for 48 ​h. Cultures were then pelleted in a centrifuge at 5000×*g* for 5 ​min. Supernatants were removed, aliquoted into a 96-well black clear bottom plate, and the absorbance was measured at 340 ​nm in a Biotek Synergy 4 plate reader (BioTek, USA). For cultures expressing *rppA* variants in LB, the supernatants were too opaque with red product and needed to be diluted 1:5 in fresh LB for accurate absorbance measurements. Supernatants of strains cultured in minimal medium were not diluted before absorbance measurements.

Samples for intracellular targeted proteomic analysis were grown for 48 ​h in 5 ​mL LB supplemented with 0 ​mM or 100 ​mM glucose. Then, 2 ​mL of the culture were then pelleted by centrifugation, the supernatant was decanted, and the pellets were stored at −80 ​°C. Proteins were extracted and analyzed using a variation of a previously-described workflow ([@bib6]).

4.9. Flaviolin purification {#sec4.9}
---------------------------

An overnight culture of *P. putida* KT2440 carrying pBADT-rppA-NT was diluted 1:100 into 100 ​mL of LB supplemented with 25 ​mg/L kanamycin, 0.2% *w*/*v L*-arabinose, and 100 ​mM glucose. The culture was shaken for 48 ​h at 30 ​°C in a 500 ​mL baffled Erlenmeyer flask. Following fermentation, the red supernatant was removed, acidified with 10 ​mL 10 ​*N* HCl, and extracted twice with equal volumes of ethyl acetate. The combined organic phase was evaporated leaving a black solid, which was then dissolved in ethyl acetate and methanol (7:3). The extract components were then separated using preparative thin layer chromatography (TLC, silica gel). The red band was isolated from the TLC plate, extracted with methanol, and filtered. The methanol was evaporated *in vacuo* leaving dark red solid with a yield of \~6.5 ​mg. The identity of the flaviolin was then validated with ^1^H-NMR. ^1^H-NMR (400 ​MHz, CD~3~OD) *δ* 6.99 (s, 1 ​H), 6.47 (s, 1 ​H), 5.58 (s, 1 ​H) ([Figs. S5A and S5B](#appsec1){ref-type="sec"}) ([@bib51]).

4.10. Synthesis of coumaroyl-CoA standard {#sec4.10}
-----------------------------------------

Coumaroyl-Coenzyme A (**2**) was synthesized in two steps according to [Scheme 1](#sch1){ref-type="fig"}. *S*-phenyl (*E*)-3-(4-hydroxyphenyl)prop-2-enethioate (**1**) was synthesized according to previous literature ([@bib18]). 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (WSCD·HCl, 1.48 ​g, 7.3 ​mmol), 1-hydroxybenzotriazole (HOBt, 1.12 ​g, 7.3 ​mmol), and 4-hydroxycinnamic acid (1 ​g, 6.1 ​mmol) were dissolved in DMF (100 ​mL) and stirred for 1 ​h ​at room temperature. Thiophenol (0.610 ​mL, 6.1 ​mmol) was subsequently added to the mixture and stirred overnight at room temperature. After the solvent was removed *in vacuo*, water and dichloromethane (DCM) were added to the mixture. The organic layers were combined, dried over Na~2~SO~4~, and evaporated. The product was purified with silica-gel column chromatography and eluted with DCM to yield *S*-phenyl (*E*)-3-(4-hydroxyphenyl)prop-2-enethioate as a white solid (**1**, 468 ​mg, 30%).Scheme 1.Scheme 1

To synthesize coumaroyl-CoA (**2**), coenzyme A lithium salt (7.7 ​mg, 10 ​μmol) was dissolved in a solution of saturated sodium bicarbonate (750 ​μL) which had been pre-chilled to 4 ​°C. *S*-phenyl (*E*)-3-(4-hydroxyphenyl)prop-2-enethioate (30 ​mg, 117 ​μmol) was added to the solution. The solution was mixed for 16 ​h at 4 ​°C then quenched via the addition of 6 ​M HCl to bring the pH of the solution to \~2. The mixture was extracted with ethyl acetate (2 ​× ​2 ​mL), then coumaroyl-CoA was purified from the remaining aqueous phase via preparatory HPLC.

Coumaroyl-CoA was purified using an Agilent 1260 series preparatory HPLC system equipped with a 900 ​μL sample loop and a UV detector coupled to a fraction collector. Compounds were separated over an Agilent Zorbax SB-C18 preparatory column (9.4 ​× ​50 ​mm, 5 ​μm particle size) using a mobile phase composed of 10 ​mM ammonium formate, pH 4.5 (solvent A) and methanol (solvent B) using the following method:Time (min)%A%BFlow rate (mL/min)095510195510859510105951011955101695510

The fraction collector was programmed to collect peaks absorbing at a wavelength of 260 ​nm and that eluted between 3.6 and 4.6 ​min. The fractions containing coumaroyl-CoA were identified by direct infusion onto an Applied Biosystems 4000 QTRAP mass spectrometer system operating with the following parameters: Q1 MS mode, scan range 100--1000 m/z, declustering potential: 70, entrance potential: 10, curtain gas: 10, IonSpray Voltage: 4800, Temperature: 300, Ion Source Gases: 40. Fractions containing coumaroyl-CoA were combined and lyophilized, yielding coumaroyl-CoA as a white powder (6 ​mg.

4.11. LC-MS/MS analysis of intracellular coenzyme a esters {#sec4.11}
----------------------------------------------------------

*P. putida* KT2440 and *P. putida* Δ*ech* cells carrying pBADT-*fcs* were cultured overnight. Cultures were inoculated 1:100 into 25 ​mL LB supplemented with 100 ​mM glucose and 0.2% w/v L-arabinose. Cells were cultured at 30 ​°C for 7 ​h then coumarate was added to a final concentration of 5 ​mM 10 ​mL of culture were taken at hours 8, 11, and 19 and pelleted in a centrifuge. Cell pellets were resuspended in 1 ​mL ice cold methanol and stored at −80 ​°C until workup.

Coenzyme A esters were extracted as follows: to the 1 ​mL methanol resuspensions, 0.5 ​mL of ice cold LC grade water and 0.25 ​mL ice cold LC chloroform. Samples were vortexed to mix after each addition. Samples were then centrifuged at maximum speed for 2 ​min to promote phase separation, after which 0.5 ​mL of the top aqueous phase was removed and transferred to an Amicon 3 ​kDa molecular weight cutoff centrifuge filter (Sigma Aldrich, USA). Extracts were filtered by spinning in a benchtop centrifuge at 4 ​°C for 90 ​min at 13000 ​g. The flow through was lyophilized for 24 ​h to concentrate the sample. Lyophilized fractions were resuspended in 0.1 ​mL of ice cold 60:40 (v/v) LC grade acetonitrile: LC grade water, and 35 ​μL of the aqueous layer was removed for LC-MS/MS analysis.

CoA extracts were analyzed using an Applied Biosystems 4000 QTRAP mass spectrometer coupled to an Aglient 1100--1200 series HPLC. Compounds were separated over a Phenomenex Kinetex XB-C18 column (100 ​× ​3 ​mm, 100 ​Å, 2.6 ​μm particle size) held at 50 ​°C. The mobile phase was composed of 10 ​mM ammonium formate, pH 4.5 (solvent A) and acetonitrile (solvent B) the following LC method was used:Time (min)%A%BFlow rate (μL/min)098240029824005.52984008.52984009.598240012.75982400

The mass spectrometer was operated in positive ion mode using the following parameters: Curtain gas: 20 ​L/min, Collision gas: medium, Ionspray voltage: 4500 ​V, Temperature: 250 ​°C, Ion source gas 1: 20 ​L/min, Ion source gas 2: 10 ​L/min, Declustering potential: 0, Entrance potential: 10, Collision cell exit potential: 10. Coumaroyl-CoA was detected in multiple reaction monitoring (MRM) mode by monitoring the following transition: 914.16 ​m/z → 407.16 ​m/z using a collision energy of 47.8 ​V. Data was imported into Skyline targeted mass spectrometry environment (v. 3.7.0 11317) and peaks were integrated using Skyline's embedded integration function. Coumaroyl-CoA was quantified relative to a standard curve that was generated by calculating the linear regression of 3 individual injections of each concentration within the standard curve (R^2^ ​= ​0.9982).

Contributions {#sec5}
=============

Conceptualization, M.R.I., M.G.T., J.M.B; Methodology, M.R.I., M.G.T., J.M.B., Y.L.,C.J.P.; Investigation, M.R.I., M.G.T., J.M.B., Y.L., M.S., A.N.P., J.W.G.; Writing -- Original Draft, M.R.I.; Writing -- Review and Editing, All authors.; Resources and supervision, C.J.P, A.M.D., J.D.K.

Declaration of competing interest
=================================

J.D.K. has financial interests in Amyris, Lygos, Demetrix, Napigen and Maple Bio.

Appendix A. Supplementary data {#appsec1}
==============================

The following is the Supplementary data to this article:Multimedia component 1Multimedia component 1

We would like to thank Professor Mattheos Koffas for providing us with the plasmid pEMT6-4CL-CUS. We thank Jesus Barajas for his careful reading of this manuscript and helpful suggestions during preparation. We also thank Morgan Price for assistance in analyzing RB-TnSeq data.

This work was part of the DOE Joint BioEnergy Institute (<https://www.jbei.org>) supported by the U. S. Department of Energy, Office of Science, Office of Biological and Environmental Research, supported by the U.S. Department of Energy, Energy Efficiency and Renewable Energy, Bioenergy Technologies Office, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The views and opinions of the authors expressed herein do not necessarily state or reflect those of the United States Government or any agency thereof. Neither the United States Government nor any agency thereof, nor any of their employees, makes any warranty, expressed or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (<http://energy.gov/downloads/doe-public-access-plan>).

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.mec.2019.e00119>.
